Ours is the Novo Nordisk Foundation
The Novo Nordisk Foundation is the major shareholder of Novo Nordisk. By funding
research and supporting life science, the Novo Nordisk Foundation turns what Novo
Nordisk makes into something greater.
Over the last 5 years, the Novo Nordisk Foundation has awarded more than 2.4 billion
USD in grants to research & development that actively improves people’s lives and the sustainability of society.